MAPT and Alzheimer disease: These results indicate that senegenin can enhance the ability of Ub to recognize and bind abnormally accumulated proteins, increase E3 expression and proteasome activity, thereby clearing the abnormal deposition of Aβ and Tau in the brain of AD rats, protecting the structural and functional integrity of neurons, and restoring the vitality of nerve cells.